EllaOne moves closer to European OTC debut

22 January 2015 - Deborah Wilkes

Archived

HRA Pharma said its emergency contraceptive EllaOne (ulipristal acetate) would be available without a prescription in some European countries from February 2015, following the European Commission's authorisation of the switch from prescription to non-prescription status throughout the European Union. The switch is proving controversial in a small number of countries, including Poland, but HRA said that it aimed to have "constructive" discussions with authorities to enable EllaOne to be "made available OTC in all countries".

Click tags below for more information on topics:

HRA Pharma

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: